Back to top

Image: Shutterstock

Top Ranked Momentum Stocks to Buy for March 11th

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 11th:

Northrim BanCorp, Inc. (NRIM - Free Report) : This provider of commercial banking products and services to businesses and professional individuals has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 22.9% over the last 60 days.

 

Northrim BanCorp’s shares gained 30.2% over the last one month against the S&P 500’s decline of 0.3%. The company possesses a Momentum Score of B.

 

Olympic Steel, Inc. (ZEUS - Free Report) : This processor and distributor of metal products has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

 

Olympic Steel’s shares gained 80.6% over the last one month. The company possesses a Momentum Score of A.

 

Rocky Brands, Inc. (RCKY - Free Report) : This designer, manufacturer, and marketer of footwear and apparel has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 25% over the last 60 days.

 

Rocky Brands’ shares gained 29.1% over the last one month. The company possesses a Momentum Score of B.

 

Matador Resources Company (MTDR - Free Report) : This independent energy company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

 

Matador Resources’ shares gained 30.2% over the last one month. The company possesses a Momentum Score of A.

 

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>